Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07792200

Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis

The goal of this interventional, prospective study is to determine the clinical utility of a repeat point-of-care ultrasound of the gallbladder in adult emergency department patients with abdominal pain for which initial imaging is not diagnostic. The main question it aims to answer is: Does a repeat ultrasound improve early identification of gallbladder inflammation?

Participants will undergo a repeat ultrasound of the gallbladder while still in the emergency department and will be followed up to determine subsequent diagnoses, disposition, consultations and other clinical information.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Acute cholecystitis is a frequent cause of abdominal pain leading to emergency department (ED) evaluation and accounts for approximately 200,000 cases annually in the US (1). Ultrasound (US) is the first-line diagnostic test, but early disease may produce equivocal or negative findings. This diagnostic uncertainty can lead to delayed treatment or the need for additional imaging, such as computed tomography (CT) or a hepatobiliary iminodiacetic acid (HIDA) scan. Recent research has shown that inflammatory changes of the gallbladder may evolve over several hours during the acute presentation. Repeat point-of-care ultrasound (POCUS) evaluations have the potential to identify interval development of clinically relevant findings, including gallbladder wall thickening, pericholecystic fluid, common bile duct dilation, and focal tenderness (sonographic Murphy's sign) (2). Despite this rationale, there is currently no prospective evidence supporting repeat POCUS examinations in ED patients with suspected cholecystitis.

Objectives

  • To assess the role of a repeated biliary point-of-care ultrasound (POCUS) examination in ED patients with an initial US equivocal or negative for acute cholecystitis.
  • To determine if a repeated biliary POCUS examination in the ED improves the diagnostic accuracy for acute cholecystitis.

The investigators hypothesize that a repeat biliary POCUS will improve diagnostic accuracy for acute cholecystitis in ED patients with an initially equivocal or negative ultrasound.

The investigators will conduct a prospective, single arm, interventional cohort study of adult ED patients presenting with right upper quadrant pain (RUQ) and clinical concern for acute cholecystitis. Patients will be eligible for enrollment if they demonstrate initial US that is negative or equivocal for acute cholecystitis, as well as ongoing symptoms prompting a general surgery consult or additional non-US advanced imaging. Consented study participants will undergo repeat biliary POCUS performed by credentialed ED physicians within 2-6 hours of their baseline US. Sonographic findings will be recorded with particular attention to interval changes to the gallbladder since the prior US. Additional data will be collected from the electronic medical record regarding clinical endpoints, including subsequent diagnoses of acute biliary pathology and the need for additional non-US imaging, consultation, or procedural intervention. The diagnostic accuracy and yield of repeat biliary POCUS will be calculated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 18 years of age
  • Presenting to the emergency department with abdominal pain with clinical concern for possible acute cholecystitis
  • Initial biliary US interpreted as normal, equivocal or negative for acute cholecystitis
  • 2-6 hours since initial biliary ultrasound with ongoing symptoms
  • General surgery consult placed or additional non-ultrasound advanced imaging ordered
  • Fluency in English or Spanish

Exclusion criteria

  • < 18 years of age
  • > 6 hours since initial biliary US
  • Asymptomatic/resolved symptoms or pending discharge from the emergency department
  • Initial ultrasound positive for acute cholecystitis or other findings to explain presenting symptoms
  • Baseline ascites
  • Prior cholecystectomy
  • Unable or unwilling to provide consent
  • Presenting to a facility other than study site emergency department
  • Transferred patients from outside facilities

Treatment and study plan

Repeat biliary point of care ultrasound

Diagnostic Test

Repeat biliary point of care ultrasound to be performed 2-6 hours following initial ultrasound imaging study

Primary outcomes

  1. Number of patients diagnosed with acute cholecystitis

    Time frame: Within 30 days of enrollment

    Diagnosis of acute cholecystitis

Secondary outcomes

  1. Interval change in gallbladder wall thickness (GWT) on repeat biliary point-of-care ultrasound

    Time frame: Within 2-6 hours of initial biliary ultrasound

    Interval change in gallbladder wall thickness (GWT) on repeat biliary point-of-care ultrasound compared to initial biliary ultrasound (measured in millimeters).

  2. Interval change in pericholecystic fluid (PCF) on repeat biliary point-of-care ultrasound

    Time frame: Within 2-6 hours of initial biliary ultrasound

    Interval change in PCF on repeat biliary point-of-care ultrasound compared to initial biliary ultrasound (assessed as present, absent, increased, decreased or no change).

  3. Interval change in focal tenderness over the gallbladder (sonographic Murphy's sign (SMS))

    Time frame: Within 2-6 hours of initial biliary ultrasound

    Interval change in focal tenderness over the gallbladder (SMS) on repeat biliary point-of-care ultrasound compared to initial biliary ultrasound (assessed as present, absent or no change).

  4. Interval change in gallbladder diameter (GBD) on repeat biliary point-of-care ultrasound

    Time frame: Within 2-6 hours of initial ultrasound

    Interval change in GBD on repeat biliary point-of-care ultrasound compared to initial biliary ultrasound (measured in centimeters).

  5. Interval change in common bile duct (CBD) diameter on repeat biliary point-of-care ultrasound

    Time frame: Within 2-6 hours of initial ultrasound

    Interval change in CBD diameter on repeat biliary point-of-care ultrasound compared to initial biliary ultrasound (measured in millimeters).

  6. Number of patients diagnosed with other biliary pathology

    Time frame: Within 30 days of enrollment

    Diagnosis of other biliary pathology, including choledocholithiasis, cholangitis, pancreatitis, biliary dyskinesia or other new diagnosis involving the gallbladder, biliary ducts or pancreas.

  7. Number of patients requiring specialty consultation

    Time frame: Within 30 days of enrollment

    Need for surgery, gastroenterology or other specialty consultation

  8. Number of patients requiring additional non-ultrasound imaging modalities

    Time frame: Within 30 days of enrollment

    Use of other non-ultrasound imaging modalities, including computed tomography, hepatobiliary iminodiacetic acid scan, or magnetic resonance imaging.

  9. Number of patient requiring biliary interventions

    Time frame: Within 30 days of enrollment

    Need for cholecystectomy, cholecystostomy tube, endoscopic retrograde cholangiopancreatography or other procedural biliary intervention

Study contacts

Contact information is provided by the study sponsor or research team.

Brent Becker Principal Investigator, MD

CONTACT

[email protected]

717-851-4819

Kristen Wilhelm Research Coordinator, MS

CONTACT

[email protected]

717-812-5075

Sponsors and collaborators

Lead sponsor

WellSpan Health

Other

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Aug 28, 2026
Registry last updated
Aug 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.